|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Cymabay Therapeutics, Inc. (CBAY) |
|
|
$32.48 0.00 (0.00%) as of 4:30 Thu 3/21
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
114,780,000 |
| Market
Cap: |
3.73(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$7.47 - $32.48 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing and providing access to therapies for patients with liver and other chronic diseases. Co.'s pipeline includes the following clinical stage product candidates: seladelpar, a selective agonist for the peroxisome proliferator-activated receptor delta, which is a nuclear receptor that regulates genes involved in bile acid/sterol, lipid, and glucose metabolism, and regulation of certain inflammatory cells; and MBX-2982, which targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
51,301 |
| Total Buy Value |
$0 |
$0 |
$0 |
$100,037 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
6,000 |
235,302 |
552,511 |
672,611 |
| Total Sell Value |
$191,849 |
$4,692,766 |
$8,944,114 |
$10,085,429 |
| Total People Sold |
1 |
5 |
6 |
7 |
| Total Sell Transactions |
1 |
14 |
33 |
36 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Von Emster Kurt |
Director |
– • – |
2015-08-13 |
4 |
B |
$2.68 |
$84,161 |
D/D |
31,359 |
31,359 |
2.39 |
- |
|
| Von Emster Kurt |
Director |
– • – |
2015-07-20 |
4 |
B |
$2.81 |
$4,496,000 |
I/I |
1,600,000 |
1,600,000 |
2.1 |
- |
|
| Shah Sujal |
Chief Financial Officer |
• – – |
2015-05-18 |
4 |
B |
$3.40 |
$34,000 |
D/D |
10,000 |
20,000 |
2.74 |
- |
|
| Van Wart Harold |
President and CEO |
• • – |
2015-05-18 |
4 |
B |
$3.28 |
$25,039 |
D/D |
7,500 |
7,958 |
2.81 |
- |
|
| Mcwherter Charles |
Sr. Vice President |
• – – |
2015-05-15 |
4 |
B |
$3.14 |
$6,318 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| Shah Sujal |
Chief Financial Officer |
• – – |
2014-09-16 |
4 |
B |
$7.44 |
$74,400 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| Goldfischer Carl |
Director |
– • – |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
46,729 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,446 |
|
- |
|
| Alta Embarcadero Biopharma Partners III Llc |
10% Owner |
– – • |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
960,433 |
|
- |
|
| Alta Embarcadero Biopharma Partners III Llc |
10% Owner |
– – • |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
88,169 |
|
- |
|
| Van Wart Harold |
President and CEOOfficer |
• • – |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
458 |
|
- |
|
| Versant Side Fund Ii, Lp |
10% Owner |
– – • |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
28,474 |
|
- |
|
| Versant Side Fund Ii, Lp |
10% Owner |
– – • |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,020,127 |
|
- |
|
| Von Emster Kurt |
Director |
– • – |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,326 |
|
- |
|
| Penhoet Edward |
Director |
– • – |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,048,602 |
|
- |
|
165 Records found
|
|
Page 7 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
